Medicines Enterprise Value:
1.609B for May 17, 2013Medicines Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 1.609B |
| May 16, 2013 | 1.609B |
| May 15, 2013 | 1.662B |
| May 14, 2013 | 1.670B |
| May 13, 2013 | 1.657B |
| May 10, 2013 | 1.682B |
| May 9, 2013 | 1.609B |
| May 8, 2013 | 1.543B |
| May 7, 2013 | 1.526B |
| May 6, 2013 | 1.526B |
| May 3, 2013 | 1.526B |
| May 2, 2013 | 1.500B |
| May 1, 2013 | 1.444B |
| April 30, 2013 | 1.500B |
| April 29, 2013 | 1.529B |
| April 26, 2013 | 1.480B |
| April 25, 2013 | 1.500B |
| April 24, 2013 | 1.483B |
| April 23, 2013 | 1.529B |
| April 22, 2013 | 1.546B |
| April 19, 2013 | 1.536B |
| April 18, 2013 | 1.476B |
| April 17, 2013 | 1.476B |
| April 16, 2013 | 1.475B |
| April 15, 2013 | 1.408B |
| April 12, 2013 | 1.448B |
| April 11, 2013 | 1.444B |
| April 10, 2013 | 1.429B |
| April 9, 2013 | 1.390B |
| April 8, 2013 | 1.412B |
| April 5, 2013 | 1.427B |
| April 4, 2013 | 1.430B |
| April 3, 2013 | 1.440B |
| April 2, 2013 | 1.450B |
| April 1, 2013 | 1.459B |
| March 28, 2013 | 1.480B |
| March 27, 2013 | 1.478B |
| March 26, 2013 | 1.477B |
| March 25, 2013 | 1.451B |
| March 22, 2013 | 1.436B |
| March 21, 2013 | 1.432B |
| March 20, 2013 | 1.417B |
| March 19, 2013 | 1.395B |
| March 18, 2013 | 1.380B |
| March 15, 2013 | 1.402B |
| March 14, 2013 | 1.401B |
| March 13, 2013 | 1.391B |
| March 12, 2013 | 1.413B |
| March 11, 2013 | 1.417B |
| March 8, 2013 | 1.387B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
MDCO Enterprise Value Benchmarks
| Companies | |
|---|---|
| Warner Chilcott | 8.315B |
| Acura Pharmaceuticals | 85.53M |
| Sagent Pharmaceuticals | 387.16M |
MDCO Enterprise Value Rankings
| Overall |
77th percentile 1744 of 7590 |
| Sector |
79th percentile 136 of 651 in Healthcare |
| Industry |
75th percentile 16 of 65 in Drug Manufacturers - Specialty & Generic |
MDCO Enterprise Value Range, Past 5 Years
| Minimum | 171.70M | Jul 1 2010 |
| Maximum | 1.682B | May 10 2013 |
| Average | 641.45M |
